NICE fails to recommend Boehringer Ingelheim and Lilly Alliance’s empagliflozin
The treatment has been developed to treat certain chronic heart failure patients and is approved elsewhere
Read More
Tag: lilly alliance
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
